AFM Registration & Regulatory Status

Meneldor B.V. is registered with the Dutch Authority for the Financial Markets (Autoriteit Financiële Markten – AFM) under the small managers registration regime pursuant to Article 2:66a of the Dutch Financial Supervision Act (Wet op het financieel toezicht – Wft).

As a registered small manager, Meneldor is not licensed as an AIFM and therefore does not fall under the full scope of prudential and conduct supervision by the AFM or De Nederlandsche Bank.

Meneldor manages specialised single-asset life sciences investment vehicles that finance the discovery and development of (bio)pharmaceutical compounds.

The investment opportunities described on this website are not publicly offered and may only be made available to:

• professional investors; or
• a limited number of investors in accordance with applicable exemptions under Dutch law.

Investments in early-stage drug development are high-risk and illiquid and investors must be able to bear the total loss of their invested capital.

By accessing this website, you acknowledge that you understand the above regulatory framework and that any investment decision must be based solely on the relevant legal offering documentation.

Last updated: March 2026